

Social prescribing has expanded rapidly in England, far exceeding initial targets of 900 000 patients by 2023–24, suggesting broad service acceptability. Progress is being made in reaching specific target groups, such as more deprived communities. However, there are still disparities in accessibility and uptake, calling for targeted strategies to address underlying inequalities.
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet